MONIKI is named in honor of the Head of Neurology and Rehabilitation Service, reflecting a commitment to advancing brain health and functional recovery. In a discussion on Radio 1, MF Vladimirsky, the chief freelance neurologist of the Ministry of Health of the Moscow Region, commented on an experiment led by American entrepreneur Elon Musk. The project involves a Neuralink implant designed to enable device control through thought. The neurologist noted uncertainty about the specifics of what was implanted in the test subject and the exact aims of the test.
“Today, glasses can be controlled by eye gaze, and some systems respond to physical cues such as pupil dilation and eye movements. These technologies exist, but the idea of harnessing thought to control devices represents a potential leap,” Sutormin observed.
He stressed the importance of awaiting the full results of Musk’s trial to determine its effectiveness and implications. The conversation reflects broader interest in how neural interfaces might translate into practical benefits for patients and consumers alike.
Neuralink, the American company founded by Elon Musk, announced that a first volunteer underwent implantation in the brain. Musk shared on the social platform X that the operation was successful and that initial device performance looks promising.
The overarching aim of Neuralink is to develop implants that can reside in the human brain and enable direct control of prosthetics and other devices. Musk has argued that such neural interfaces could empower people to interact with technology in new ways and may play a role in addressing future challenges posed by artificial intelligence.
There has been dialogue in various political circles about whether such chips could find a place in Russia, prompting questions about regulatory, ethical, and practical considerations for widespread adoption.